deltatrials
Terminated PHASE2 INTERVENTIONAL 2-arm NCT04945733

A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer

A Phase 2, Open-label Study of Amivantamab in Subjects With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer

Sponsor: Janssen Pharmaceutical K.K.

Conditions Esophageal Neoplasms Stomach Neoplasms
Interventions Amivantamab
Updated 26 times since 2021 Last updated: Aug 22, 2024 Started: Aug 30, 2021 Primary completion: Jul 3, 2023 Completion: Jul 3, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to reconsideration of development strategy

Other terminated trials from Janssen Pharmaceutical K.K.

See all terminations from Janssen Pharmaceutical K.K.

Other Esophageal Neoplasms trials with similar outcome

Browse all Esophageal Neoplasms trials

Listed as NCT04945733, this PHASE2 trial focuses on Esophageal Neoplasms and Stomach Neoplasms and remains terminated or withdrawn. Sponsored by Janssen Pharmaceutical K.K., it has been updated 26 times since 2021, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Aug 2023 · 2 months · monthly snapshot~Aug 2023 – ~May 2024 · 9 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

26 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Oct 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Sep 2024 — Oct 2024 [monthly]

    Terminated PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  5. May 2024 — Jul 2024 [monthly]

    Terminated PHASE2

    Status: Completed → Terminated

▶ Show 21 earlier versions

  1. Aug 2023 — May 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  2. Jun 2023 — Aug 2023 [monthly]

    Active Not Recruiting PHASE2

  3. May 2023 — Jun 2023 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2023 — May 2023 [monthly]

    Active Not Recruiting PHASE2

  5. Mar 2023 — Apr 2023 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  6. Feb 2023 — Mar 2023 [monthly]

    Recruiting PHASE2

  7. Jan 2023 — Feb 2023 [monthly]

    Recruiting PHASE2

  8. Dec 2022 — Jan 2023 [monthly]

    Recruiting PHASE2

  9. Nov 2022 — Dec 2022 [monthly]

    Recruiting PHASE2

  10. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  11. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  12. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  13. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  14. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE2

  15. Mar 2022 — Apr 2022 [monthly]

    Recruiting PHASE2

  16. Feb 2022 — Mar 2022 [monthly]

    Recruiting PHASE2

  17. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE2

  18. Dec 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  19. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  20. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  21. Sep 2021 — Oct 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Aug 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Janssen Pharmaceutical K.K.
Data source: Janssen Pharmaceutical K.K.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations